Quest Diagnostics Oncology

Quest Diagnostics Oncology is proud to support Breast Cancer Awareness Month and recognize everyone involved in the fight against breast cancer. According to the American Cancer Society, 1 in 8 women will be diagnosed with invasive breast cancer in their lifetime. Early detection can help save lives. As a single-source solutions provider, we offer tests for screening, diagnosis, treatment selection, and monitoring. Learn more: https://lnkd.in/gvU-TVpZ. #BreastCancer #BreastCancerAwarenessMonth

Watch our recent webinar with the American College of Healthcare Executives and our own Darren Wheeler MD, where you'll: 🔍 Observe how the speed to diagnosis improves with digital pathology 📈 Understand how digital pathology can help increase staffing productivity 🏥 Learn how AI helps address the current workforce shortage of pathologists Click below to watch now.

Please join us in welcoming Karin Miller, MD! Dr. Miller is board-certified in Anatomic and Clinical Pathology, Hematopathology, and Molecular Genetic Pathology and is located at Quest Diagnostics in San Juan Capistrano, CA. #WelcomeWednesday #newteammember

Do you have a family history of cancer? Do you want to understand more about genetic testing? Visit our patient’s guide to understanding hereditary cancer genetic testing to learn more: https://lnkd.in/eVftMTdx

The Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT) supports updated NCCN Guidelines®, released on August 8, 2024, that expand access to hereditary cancer genetic testing for colorectal, endometrial, and gastric cancer patients. INTERACT serves as a collective voice in support of evidence-based access to genetic testing for people with or at risk of hereditary cancers and works to drive awareness and inform changes that will equalize access for those whose outcomes could benefit most from genetic testing. Members of the coalition include: AliveAndKickn; Ambry Genetics, a subsidiary of REALM IDx, Inc.; FORCE: Facing Our Risk of Cancer Empowered; Illumina; Let's Win Pancreatic Cancer; Myriad Genetics; Ovarian Cancer Research Alliance ; Quest Diagnostics; and ZERO Prostate Cancer. Learn more at: https://lnkd.in/ezj3nwYQ

Please join us in welcoming Annamarie L. Carley, MD! Dr. Carley is board-certified in Anatomic and Clinical Pathology and is located at Quest Diagnostics in Las Vegas, NV. #WelcomeWednesday #newteammember

As AI and other technological advances continue to change the oncology landscape, it’s important to partner with a lab that equips pathologists with the tools to work more efficiently. Get the ‘whole’ picture of cancer with the power of digital pathology. Learn more here: https://lnkd.in/eDa-yW2H

As AI advancements progress, digital pathology will continue to elevate cancer diagnosis, treatment, and maintenance for both patients and providers. That’s what Dr. Darren Wheeler, VP of Pathology and Medical Services at Quest Diagnostics, discusses in our latest episode of Diagnostic Dialogues. Listen to the episode below: https://lnkd.in/gKbsbf-A  

One of our heroes whom we want to recognize during #BreastCancerAwarenessMonth is pathologist Darren Wheeler MD. As the vice president of pathology and medical services at Quest Diagnostics and AmeriPath®, Dr Wheeler works tirelessly to provide key insights to providers on our most challenging cases. Learn how Quest is committed to doing more for you and your patients: https://lnkd.in/dQuwTyAi #breastcancer #breastcancerscreening #healthcareheroes

Please join us in welcoming Thomas Cibull, MD! Dr. Cibull is board-certified in Dermatopathology, and Anatomic and Clinical Pathology and is located at Quest Diagnostics in Schaumburg, IL. #WelcomeWednesday #newteammember